science wire

A new study has found stark differences in the dementia care received by people in richer and poorer neighbourhoods in Quebec, despite the universal health-care system.

Climate change makes it necessary to study and prevent the effects of insects considered harmless in our latitudes, according to Professor Davide Robbiani, director of the Institute for Research in Biomedicine (IRB) , on the pages of laRegione.

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date.

Endocrinologist Hélène Lavoie discusses this complex and often misunderstood hormonal change in men, which occurs gradually and unevenly starting as young as age 30.

A clinical trial led by researchers from UCL and UCLH, which is soon to get underway, aims to transform the lives of lupus patients who don't respond to current treatments.

An international panel of experts, including Markus Zeitlinger from the Medical University of Vienna, has presented a systematic review of the effect and dosage of antibiotics in patients with obesity.

A kinder treatment for anal cancer involving a lower dose and shorter course of radiotherapy is more effective than traditional treatment, a clinical trial led by Leeds researchers has found.

An innovative blood cancer treatment regime could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer Jean Abraham In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100% of patients survived the critical three-year period post-surgery.

People living in more deprived areas with worse health outcomes were 65% more likely to lose their local pharmacy than those in wealthier areas, according to research published today.

Why do some drugs cause hallucinations while others don't - even when they act on the same part of the brain? That's the mystery at the centre of a new research project supported by  CQDM  and  Brain Canada.

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ovarian cancer. Now, Cambridge researchers have shown that this procedure - known as bilateral salpingo-oophorectomy (BSO) - is associated with a substantial reduction in the risk of early death among these women, without any serious side-effects.

ANU research shows not all'addictions are treated equally by the media. Less stigmatised reporting could save lives.

A portable device that detects illicit street drugs on the spot and at very low concentrations, highlighting the dangers they pose, has been developed at Bath.

Juliane Winkler, a researcher at the Center for Cancer Research at the Medical University of Vienna, has been awarded the Johann Wilhelm Ritter von Mannagetta Prize for Medicine by the Austrian Academy of Sciences.

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency-I, or LAD-I, in an international clinical trial co-led by UCL.

Elderly colon cancer patients are being given the chance to access a clinical trial that could transform future practice.

Elderly colon cancer patients are being given the chance to access a clinical trial led by the University of Leeds that could transform future practice.

Schulich prof's patients report 'life-changing' results with combination of glucose monitoring and automated insulin pump Lisa Mercer had tried just about everything to regulate the ups and downs of her blood sugars, from a strict diet to medication to four-a-day-day insulin shots.

World Immunisation Week, 24-30 April: Asel Sartbaeva's EnsiliTech team plans to harness 'ensilication' to deliver antibody treatments and reduce hospital stays.

Western and Schmidt Initiative for Long Covid will enroll more than 300 patients across four continents Spanning four continents and enrolling hundreds of people, a new clinical trial led by scientist

The Royal Veterinary College (RVC) has led novel research on India's 2019 ban on the use of colistin in livestock, providing a framework to approach the regulation of other critically important groups of antibiotics being used in livestock.

Researchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to atherosclerosis, which could prevent unnecessary surgeries and stents. Atherosclerosis is a condition where the blood vessels become narrowed and hardened due to the buildup of plaque, including in the carotid arteries, which carry blood from the heart to the brain.

Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to break through and destroy bacterial biofilms. This offers a promising solution that could address the global crisis of chronic antibiotic-resistant infections affecting hundreds of millions of people worldwide.

People in police custody with health issues are regularly put at risk because medication is delayed or unavailable.

A mid-afternoon puff could be the best way to get the most out of your asthma inhaler according to a new study led by University of Manchester researchers. The study, funded by the Jon Moulton Charity Trust, found that a dose of inhaled beclomethasone - known as Clenil Modulite or the 'brown' steroid inhaler in the UK- could lead to better clinical outcomes if taken between 3pm and 4pm.

To diagnose lung cancer and determine the optimal treatment strategy, physicians typically rely on tissue examination.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all. These are the findings of a new study from researchers at Lund University in Sweden and Imperial College London. Their analysis suggests that treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.